Masha Fridkis-Hareli
Founder and CEO Palena Therapeutics
Masha Fridkis-Hareli, M.Sc., Ph.D. is an immunologist, consultant, entrepreneur and inventor with over 30 years of experience in academia and industry. She is Founder and CEO of Palena Therapeutics, Inc, a start-up company that designs and develops autoimmune disease therapies, and Founder and President of ATR, LLC, where she provides scientific consulting and laboratory services in immunoassay development. Dr. Fridkis-Hareli has held a variety of positions in both academia and industry and is a co-author of over 100 publications and 18 issued patents.
Seminars
Wednesday 1st April 2026
Reprogramming Protein Therapeutics to Restore Immune Balance in Animal Models
4:45 pm
- Advancing a novel protein platform toward safer, precision treatments for inflammatory disease
- Leveraging embedded epitope random copolymer proteins to reprogram immunity without suppressing healthy responses
- Demonstrating disease-specific efficacy in multiple animal models of Crohn’s disease, uveitis, and multiple sclerosis
